Process Automation Inflected on Schedule and the Guide Rose Again, Yet the Stock Sits 10% Below Our Upgrade: Maintaining Outperform, Fair Value $239–260

Results vs. Consensus

Q3 2026 Scorecard

Year-over-Year Comparison (Q3 2026 vs. Q3 2025)

Sequential Comparison (Q3 2026 vs. Q2 2026)

Revenue

Reported revenue of $4,994M missed the ~$5.01B consensus by $16M, or 0.3%, and landed at the top of the $4.9–5.0B range issued in July. We do not read the shortfall as a demand signal. Organic growth rose to 7% from Q2's 4% and is the first print above the three-year algorithm, and the gap between reported and organic is a perimeter effect: divestitures removed 8 points and the Johnson Matthey Catalyst Technologies acquisition added 2. The growth was broad. Building Automation products grew 11%, Process Automation projects grew 14% and Industrial Automation solutions grew 16%. The only flat line in the segment detail was Industrial Automation products, where sensing grew double digits and utility meter deferrals offset it.

Margins

Segment margin of 21.3% was up 370bp year over year and 230bp sequentially. Management's bridge assigns about 70bp to volume leverage and about 350bp of headwind to inflation, more than offset by pricing, productivity and stranded-cost removal, and puts net price/cost at roughly +30bp. Our own decomposition of the same result by line of the segment table is more revealing. The three segments' combined margin rose from 22.5% to 23.3%, about 80bp, and part of that is mix, since the divested Industrial Automation businesses carried lower margins. Corporate and all other fell from 4.9% of sales to 2.0%, about 290bp. Of that, $36M is trademark licensing income booked inside segment profit for the first time, worth about 70bp. The remainder, roughly 215bp, is the stranded-cost program. GAAP gross margin rose 440bp to 40.4%, though part of that reflects lower repositioning charges and the exit of lower-margin divested businesses.

EPS

Adjusted EPS of $2.27 rose $0.57 year over year. Adjusted net income was $724M, about $181M above the year-ago level implied by $1.70 on 319.4M shares. On our arithmetic at a ~21% tax rate, segment profit growth of $196M explains about $0.49 per share and lower net interest (interest charges down $120M, interest income down $35M) about $0.21, against a $0.20 drag from stock compensation, which rose to $104M from $22M. Management's commentary matches that shape: operational performance in all three segments overcame the lost income of the divested businesses, and lower interest more than offset a slightly higher tax rate. The beat is operational. Below the line, lower interest helped, but the increase in stock compensation offset almost all of it. GAAP EPS of $2.40 includes a $339M pre-tax gain on a business sale ($0.67) and pension income ($0.21), partly offset by the $147M Quantinuum equity loss ($0.35) and acquisition amortization ($0.32), all excluded from the adjusted figure.

Segment Performance

Process Automation's reported growth includes 8 points from the acquired catalyst business; Industrial Automation's reported decline includes 27 points of divestitures. The Q2 corporate figure is implied: $1,171M of three-segment profit against $985M reported.

Nine-Month View

The full-year guide of about 20.5% on roughly $20.05B of sales implies about $1.12B of fourth-quarter segment profit on about $5.05B of sales, a 22.2% margin, consistent with management's "approximately 22%."

Process Automation & Technology: The Inflection Arrived, and It Arrived Diluted

This was the quarter the investment case most needed, and it delivered the revenue. Organic growth swung to +8% from −1% in Q2. Projects grew 14% on LNG and petrochemical backlog conversion, and aftermarket returned to growth at +4%, led by catalysts that grew double digits overall and 80% in refining. Segment backlog is more than 10% higher than a year ago, and management says it has booked more than $1B of process technology orders since the first quarter. The geographic spread matters: North American LNG, refining and petrochemical builds in Africa (management cited the Dangote refinery doubling and a new Kenyan refinery), and continued activity in the Middle East and Asia.

"Additionally, the growth inflection we expected in Process Automation and Technology is occurring with the business growing 8% organically in third quarter." — Vimal Kapur, Chairman & CEO

The cost of that growth showed up in the margin. Segment margin fell 210bp to 22.2% on two expected sources, project-heavy mix and dilution from the acquired catalyst business, and management guided 21.5% for the fourth quarter and something similar for the first half of 2027. Expansion is not expected until the second half of 2027, once integration is substantially complete and catalyst volumes mix up, with a further step in 2028. On the positive side, management said the acquired business is generating higher cost synergies than forecast, which matters because the July deal was underwritten on cost synergies alone at about 13x 2027 EBITDA.

"So versus where the team finished at the 22.2% I would say next quarter, 21.5%. And then in the first half, I would say probably something similar. But next year, P and T is going to expand margins." — Michal Stepniak, SVP & CFO

Assessment: In July we called this segment the single point of failure for the guide and asked for a high-single-digit inflection in the second half. We got +8% in the first quarter of the half, so the revenue risk we were underwriting is largely retired. What replaces it is a margin question. A segment growing high single digits at 21.5–22% margins for three more quarters is still accretive in dollars, but it will hold consolidated margin expansion below what volume alone would suggest. There is also a quiet tension in the outlook. The 2027 margin recovery leans on catalyst mix, yet management described 2027 catalyst growth as "more normalized" at mid-single digits after mid-to-high-teens growth in the fourth quarter. We would want the February guide to reconcile those two statements.

Building Automation: Eighth Straight High-Single-Digit Quarter, With Less Margin Leverage

Building Automation grew 8% organically, its eighth consecutive high-single-digit quarter. Products grew 11% on fire and security, and solutions grew 4% on services, with double-digit growth in India and Asia Pacific. Management attributes the share gains to new product introductions, connected offerings that pull through core hardware (remotely configurable fire panels), differentiated early-detection products for data centers and lithium-ion batteries, and the globalization of the acquired access-control franchise. The higher-growth verticals (data centers, health care and hospitality) are about 20% of the segment and the core 80% grows mid-single digits.

"The momentum in building automation continued with 8% organic growth. Our 8th straight quarter of high-single-digit growth, evidence that we continue to gain share in the market." — Michal Stepniak, SVP & CFO

Margin was the softer line. Segment margin rose only 30bp to 27.0%, against 90bp in Q2, because pricing actions did little more than offset inflation. Management guided 70–90bp of expansion in the fourth quarter.

Assessment: Growth is not in question here. Eight consecutive high-single-digit quarters on a business historically described as low growth is a share story, and management's own breakdown (20% of the segment in faster verticals, 80% core at mid-single digits) suggests the segment's sustainable rate is mid-to-high single digits rather than the "mid-single-digit plus" in the guide. The margin, however, is no longer expanding much: 30bp is a third of Q2's 90bp. In a 27% margin business, with inflation costing roughly 350bp of margin company-wide, that is acceptable, but this segment will not supply much of the 2027 margin bridge.

Industrial Automation: The Margin Is Real, Half of the Next Step Is Mechanical, and Delivery Is Behind

Industrial Automation grew 4% organically and fell 23% reported as the divested businesses left. Solutions grew 16% on industrial measurement and utilities, while products were flat: sensing grew double digits but utilities deferred gas and water meter deployments while each utility runs its own testing of new meter technology. Management expects that testing cycle to take six to nine months and rollouts to begin in 2027. Segment margin rose 350bp to 18.4% on price and productivity, and core orders grew 15%, giving the segment what management described as probably its best backlog in more than five years.

The fourth-quarter target of 22% is now better understood. The CFO said the business is expanding about 150bp or more on operations alone and the rest of the step from 18.4% comes from the divestiture perimeter. On delivery, the on-time rate is now about 60%, up from just under 40%, with past-due orders down 18%. Management cited a 25% margin goal for 2029 and expects growth to move from low to mid-single digits in 2027.

"So, actually, the low growth in our metering business is actually already factored in 2026 and potentially in 2027. But looking ahead, it is gonna turn into a tailwind when the adoption rates will pick up, in the period ahead." — Vimal Kapur, Chairman & CEO

Assessment: Two things in this segment run behind what we were told in July. In Q2, management described delivery performance as "trending from 40% towards 80% as we speak," and we listed clearing 80% as a Q3 signpost. It is at 60%. And the 22% fourth-quarter margin, which we called the most falsifiable commitment on the July call, turns out to be roughly half portfolio arithmetic. Neither is a thesis break, because orders up 15% and a 350bp margin gain are what a working turnaround looks like. But the metering deferral now extends into 2027 and the delivery metric is slower than implied, so we treat the 2027 mid-single-digit growth target as a plan, not a forecast.

Key Topics & Management Commentary

Overall Management Tone: Confident and operational, with fewer superlatives than July and a sharper focus on the 2027 setup. Management leaned on quantified commitments (stranded costs gone by year-end, about $400M of corporate cost in 2027, more than 100% cash conversion in the fourth quarter) and was most defensive where the numbers were softest, presenting orders on a normalized basis and attributing the trimmed fourth-quarter margin to mix. The Quantinuum stake, which management promised in July to address by early next year, did not come up at all.

1. Grading the Q2 Commitments

Our July recap ended with ten signposts for this quarter. Five were met or beaten, three were partial, and two drew no update.

"We delivered 7% organic sales growth above the high end of the targets we unveiled at Investor Day in June." — Vimal Kapur, Chairman & CEO

Assessment: The scorecard is good on operations. The PA&T inflection, the operating condition the July upgrade depended on, was met, and the stranded-cost schedule was beaten. Two of the three partial grades concern the margin trajectory beyond the corporate line, and that is where we now focus. The balance-sheet half of the July case, Quantinuum, drew no update.

2. Why Management Calls the Energy Cycle Multiyear

Management framed Process Automation's growth as the start of a multiyear upcycle driven less by the oil price than by energy security, regional refining build-outs and low-carbon fuels. The evidence offered was specific: more than $1B of process technology orders since the first quarter, segment backlog up more than 10%, two carbon-capture wins in the quarter, about 100 sustainable aviation fuel projects licensed of which only about 20% have been built, and refinery expansions in Africa. A questioner noted Brent above $110; management's answer was that the drivers sit elsewhere.

"it is less linked to the oil price. it is more linked to the drivers, which are more broader in energy security, resiliency, low carbon fuels, or the broader demand of petrochemicals. And that is why we believe it is a multiyear cycle." — Vimal Kapur, Chairman & CEO

There is one offset in the near term. High refinery utilization is deferring shutdown-dependent work such as pump replacement and catalyst refurbishment, which management described as demand moving right rather than lost.

Assessment: The breadth of the project pipeline is the most credible part of this argument, because a cycle spread across LNG, African refining, Middle East refurbishment and low-carbon fuels does not depend on one region or one commodity price. The weaker link is the aftermarket, which is the high-margin part of the segment and the part most exposed to refiners running hard and deferring turnarounds. A multiyear project cycle with a lagging aftermarket is exactly the mix that produces revenue growth with margin dilution, which is what this quarter showed.

3. Where the 370bp Came From

Management's bridge credited about 70bp to volume leverage, the bulk to pricing, productivity and stranded-cost removal, and charged about 350bp to inflation. Net price/cost was about +30bp, and price is expected to average about 4.5% in the second half and 4% for the year, with inflation persisting at least into the first half of 2027 before easing. The segment table tells a complementary story. The corporate line shrank by $140M, which is about 290bp of the 370bp. That includes $36M of trademark licensing income, which the release shows inside segment profit for the first time this quarter and which we take to be the Aerospace trademark agreement management cited on the July call.

"Price to cost in the third quarter was about 30 bps net positive." — Michal Stepniak, SVP & CFO

Assessment: In July we noted that the trademark agreement had never been sized. It now has a run rate: $36M a quarter is roughly $145M a year, about 70bp of margin, and on our reading it is a contractual receipt from a separate company rather than a productivity gain. It is real money and it recurs, but it should not be capitalized as evidence of operating improvement. Stripping it and the stranded-cost removal out, the underlying segments improved about 80bp, which is respectable for a quarter in which the largest growth segment lost 210bp to mix. The investment conclusion is that 2026's margin story has been mostly structural, as we argued in July, and 2027's will need to be more operational.

4. Stranded Costs Gone by Year-End, Ahead of Plan, and What 2027 Corporate Looks Like

In July management expected to carry $60–65M of stranded cost into 2027. It now expects to eliminate all of it by the end of 2026, which a questioner called about six months earlier than expected and the CFO accepted. Management credits a cross-functional shared-services model and a lighter headquarters. The CFO put 2027 corporate cost at about $400M; the corporate and all-other line was $438M for the first nine months of 2026 alone.

"Importantly, with accelerated progress this quarter, we now expect to eliminate all remaining stranded costs by the end of 26. Just 6 months after the aerospace spin off demonstrating our strong execution capabilities." — Vimal Kapur, Chairman & CEO

"But for next year, just like we talked about, I think, before, we plan for our corporate cost to be about $400 million." — Michal Stepniak, SVP & CFO

Assessment: This is the cleanest execution evidence in the print and it confirms the July thesis that roughly half of the margin algorithm is mechanical. The flip side is timing. A lever that finishes early delivers its benefit early, so the year-over-year corporate tailwind that drove this quarter will shrink through 2027. If the definitions match, a corporate line of about $400M next year against roughly $540M this year is still worth about 70bp and about $0.35 per share, but it is a smaller tailwind than 2026's.

5. Orders: A Normalized View

Management presented third-quarter orders net of a large low-carbon/LNG award booked in the third quarter of 2025, one of two such awards in the third and fourth quarters of 2025 worth more than $700M combined. On that basis total orders grew 3% organically. Short-cycle orders grew 8% excluding divestitures, Industrial Automation core orders grew 15%, data center orders more than doubled, and book-to-bill was about 1.0. Backlog rose 7% to nearly $19B. For the fourth quarter, management expects high-single-digit order growth excluding last year's fourth-quarter award and said October's first three weeks were tracking at or above expectations.

"From time to time, large awards like this do not always correlate with underlying market demand we are seeing which is why we have elected to present a normalized view of the demand. Excluding the impact of Q3 award last year, total company orders are up 3% organically" — Vimal Kapur, Chairman & CEO

Assessment: The comparison argument is legitimate, since one quarter's long-cycle order rate says little when the base holds a single award worth several hundred million dollars. But the deceleration is not only long-cycle. Short-cycle growth slowed to 8% from double digits in every segment in Q2, and book-to-bill fell to about 1.0 from 1.1. Because the adjustment removes an award from last year's base, the unadjusted total must have grown less than 3%. We moved the orders pillar to on-track in July on a single quarter of +16%. Consistency requires that we move it back to at-risk on a single quarter of +3%, while giving weight to a backlog that is still growing and a fourth-quarter guide that is specific enough to grade.

6. The Fourth-Quarter Exit Rate: "Above 22%" Becomes "Approximately 22%"

In July the CFO said Honeywell Technologies would exit 2026 above 22% segment margin. This quarter the full-year guide moved to about 20.5%, the top of the prior range, but the fourth quarter is now "approximately 22%." Management attributed the difference to mix, since projects and the acquired catalyst business are growing faster and both dilute the segment margin.

"With the performance to date, we expect to be at the high end of our full year margin range at 20.5% and at approximately 22% for the fourth quarter." — Michal Stepniak, SVP & CFO

Assessment: This is a small change in wording, and the explanation is the right kind of bad news: higher-growth, lower-margin revenue rather than a cost problem. It still matters because the exit rate is the jumping-off point for 2027. Every 50bp of 2027 segment margin is worth about $0.25 of EPS on our numbers, so a 2027 that starts at 22% rather than 22.5% is a modestly lower base. We incorporate it in our 2027 estimate.

7. Data Centers Become a Pan-Honeywell Business

Data center exposure, described in July as about 5% of Building Automation, is spreading across segments. Process automation is now winning orders for on-site power islands, controls and energy storage; industrial sensing and Sundyne pumps are being qualified for liquid cooling; and management sees growth outside the US, particularly in Korea and India. Data center orders grew more than 100% in the quarter.

"We saw year to date orders growth of more than 100%. Based upon the pipeline visibility we have, we expect very high growth in 2027 also.… it is truly becoming a pan-Honeywell strategy, and we continue to improve our content." — Vimal Kapur, Chairman & CEO

Assessment: Management suggested data centers could become a mid-single-digit share of the whole company at some point. That remains small next to a $20B revenue base, and much of the liquid-cooling opportunity is, by management's own account, beyond 2027. The value is less in the size than in the cross-segment selling it demonstrates, which is a test of whether a three-segment automation company is worth more than its parts.

8. Cash Conversion: 95%, With an Asterisk

Free cash flow was $688M, up 15%, for 95% conversion of adjusted net income, and full-year free cash flow guidance rose $100M to about $2.1B. Management expects conversion above 100% in the fourth quarter on working capital, particularly receivable collections.

"We expect free cash flow conversion to be above 100% in the fourth quarter as we drive working capital improvements including strong receivable collections." — Michal Stepniak, SVP & CFO

Assessment: The headline is good and the trend is right, but two details temper it. The free cash flow definition adds back $158M of separation-related payments; operating cash flow less capital expenditure was $530M, or 73% conversion. And capital expenditure of $77M was half last year's $150M, against about $0.6B guided for the year, so the fourth quarter carries roughly $230M of capex. Receivables rose $217M in the quarter and the balance is $657M above year-end, partly from the acquisition, so the fourth-quarter target depends on collections, as management said. Separation payments of about $0.5B this year should fade in 2027, which would bring unadjusted conversion closer to the reported figure.

9. Deleveraging First: Gross Debt Below $13B by Year-End

Management reaffirmed the plan to cut gross debt from about $18B in the second quarter to under $13B at year-end, with gross leverage below 3.0x, net leverage below 2.25x, year-end cash of about $3B and net debt of about $10B. At September 30, total debt was $16.6B and cash plus short-term investments $6.2B, so net debt stood at $10.4B. M&A is described as optional and a 2027-and-later item, prioritized toward Industrial Automation sensing and measurement, then higher-growth verticals, then technology tuck-ins.

"we are committed to reducing our gross leverage to less than 3x this year by lowering our gross debt balance from $18 billion in the second quarter to under $13 billion at the end of 26." — Michal Stepniak, SVP & CFO

Assessment: Repaying debt largely from cash on hand leaves net debt roughly unchanged while cutting gross interest expense and interest income together, so the 2027 EPS benefit is smaller than the gross reduction implies. We model net interest modestly lower next year. The more useful signal is the statement that the $12 target for 2029 is "all organic," which keeps the balance sheet and any eventual Quantinuum proceeds as upside to the plan rather than inputs to it.

10. 2027: "At or Above" the Algorithm, and "$12 or Better"

Management said 2027 organic growth should be at or above the 4–6% long-term algorithm, and the CEO went further in Q&A, saying he is confident of the upper end of that range. Other 2027 markers: about $400M of corporate cost, operational margin expansion of more than 60bp, price/cost slightly positive, PA&T margin expansion in the second half, and Industrial Automation growth moving to mid-single digits. Formal guidance comes in February.

"In conclusion, we are seeing robust backlog growth and commercial momentum across our business, and we expect 2027 organic growth to be at or above our long term growth algorithm." — Vimal Kapur, Chairman & CEO

Assessment: The building blocks support low-teens EPS growth, roughly the pace of the $12-by-2029 target, rather than the 15% that a questioner said the CFO had floated earlier. Management did not endorse 15% when asked. We set our 2027 estimate at about $9.45, up 12%, which assumes the upper half of the organic range, a 22.0–22.5% segment margin, and modestly lower net interest.

11. Quantinuum: Not Mentioned, and Worth Less Than Its Book Value

The 47% Quantinuum stake was the analytical core of our July upgrade, when we argued roughly $23 per share of carrying value sat outside the headline multiple. It was not mentioned on this call. Meanwhile Quantinuum's shares fell from $49.78 on July 28 to $36.50 on October 23, down 27%, and stand 39% below the $60 IPO price. At that price the stake's market value is about $4.5B, or about $14 per HON share, against a carrying value of roughly $7.1B within the $7,273M of equity-method investments. The stake also produced a $147M pre-tax equity loss in the quarter, excluded from adjusted EPS.

"On Quantinuum, we expect to provide more color on our plans of our 47% ownership stake by early next year." — Vimal Kapur, Chairman & CEO, July 23 call

Assessment: The direction of our July argument still holds: the stake contributes nothing to the earnings the multiple is applied to, so it is value outside the screen. The magnitude does not. We carried it at $20 per share in July and now carry it at $12–14, which accounts for about $7 of the reduction in our fair value. The roughly $2.5B gap between market and book value also raises the possibility of an impairment if the decline persists, a non-cash GAAP item that would not touch adjusted EPS. The stated catalyst, a plan by early 2027, is unchanged.

Guidance & Outlook

What the guide asks of the fourth quarter. The full-year sales range less $15,004M of nine-month sales implies $5.0–5.1B for the fourth quarter, down about 3% reported from $5,212M a year ago because the divested businesses are absent for the full quarter, and up 5–6% organically. By segment, management expects continued strength in Building Automation, high-single-digit growth in Process Automation on backlog conversion and mid-to-high-teens catalyst growth, and continued sensing and measurement demand in Industrial Automation. On margin, Industrial Automation at about 22%, Building Automation up 70–90bp and Process Automation near 21.5% combine to about 22% overall.

Street at: Third-quarter consensus was $2.16–2.17 of adjusted EPS on about $5.01B of revenue. The $0.23 midpoint raise to the full-year guide is larger than the third-quarter beat, whether measured against that consensus ($0.10–0.11) or against the midpoint of the July outlook (about $0.15), so the new guide also embeds a higher fourth quarter than the old one did.

Guidance style: Conservative, by management's own description. Asked why the fourth quarter implies slower organic growth than the third despite strong backlog and short-cycle orders, the CFO called it "more of conservatism than anything else" and said current tracking is toward the higher end. The pattern since June supports that reading. Management set a standalone guide on June 8, raised it on July 23, and raised it again on October 22 so that the new low end sits above the old high end. The one place the formal guide got softer is the fourth-quarter margin wording.

Analyst Q&A Highlights

How Much Confidence to Place in a Fourth-Quarter Order Guide One Month In

The opening question went straight to the softest number in the print. With December typically a heavy bookings month, the questioner asked what supports the high-single-digit fourth-quarter order guide and what October looked like. Management answered with a current data point and a description of its forecasting method, including a contingency for slippage.

Q: "So I am curious, the confidence in 4Q order growth, we are still only 1 month into the quarter. I am assuming December is a pretty important month for bookings. I am just wondering what gives you the confidence that a pipeline converts into orders and maybe just touch on how-- what you have seen in October."
— Nigel Coe, Wolfe Research

A: "So far, Nigel, the first 3 weeks of October has been trending on and above expectations. So that is certainly is a good data point. And we look at our statistical performance against pipeline, our win rates, when we forecast it. Also provision for some adequate contingency for things which cannot happen as projected."
— Vimal Kapur, Chairman & CEO

Assessment: Three weeks of October data is thin, but it is a falsifiable claim made in public, and the guide was framed on a basis comparable to the third-quarter figure, so it can be graded cleanly in February.

Whether Industrial Automation's Margin Gains Can Continue Beyond the Fourth Quarter

A line of questioning acknowledged the segment's uneven history and asked whether margin expansion can continue past the guided fourth-quarter step, and whether a choppy macro backdrop was showing up in short-cycle orders. Management answered with operating metrics and a longer-term target.

Q: "I suppose maybe when we try and look a little bit further out, how confident are you in continued margin expansion at IA in the coming quarters? And given the macro backdrop is a bit choppy, anything concerning you have seen in the order rates of IA, the shorter cycle pieces?"
— Julian Mitchell, JPMorgan

A: "The reason for that is the basics are improving as we talked about it in Investor Day, very rapidly. Our-- of our own time delivery now is used to be just shy of 40%. it is now 60%. Our past dues are down 18%.… We expect the year to end at 22%.… we remain very confident on the margin expansion and also achieve 25% goal by 2029."
— Vimal Kapur, Chairman & CEO

Assessment: The 25% margin goal for 2029 gives a three-year path to grade. The delivery figure is the more telling disclosure: 60% is real progress from below 40%, but it is well short of the 80% that the July commentary pointed toward. Delivery performance drives share in a channel business, so it is the lead indicator to watch for 2027 growth.

Why the Fourth-Quarter Margin Lands at the Low End

A questioner observed that the implied fourth-quarter margin had slipped to the bottom of the range and asked whether price/cost timing or conservatism explained it. Management ruled out both and named mix.

Q: "And then just for the fourth quarter, my follow-up is what the margin went to the low end of the range, I guess, for the fourth quarter. And is that really just the price cost timing stepping up a little bit sequentially? Just curious as to that or just conservatism."
— Steve Tusa, Wells Fargo

A: "No. Not at all.… it is really just mix. So revenue is coming up.… On the other hand, projects is doing better. And the CT outlook is better, and they are dilutive to our overall mix, and that is what is dragging our margin."
— Michal Stepniak, SVP & CFO

Assessment: Of the possible explanations this is the least concerning one, since lower-margin growth is still growth. But it confirms that the fourth-quarter exit rate was trimmed, and management did not describe it as conservatism, unlike the revenue guide. We treat it as a real change to the 2027 starting point.

How 2027 EPS Growth Squares With the Margin Opportunity

A questioner pressed on why management's 2027 framing, organic growth at or above the algorithm, did not sound more ambitious given the margin levers, and contrasted it with a 15% EPS growth figure the CFO had reportedly floated. Management laid out the building blocks and deferred specifics to February.

Q: "I think, Mike, maybe a couple months ago, you sort of floated this idea of 15% EPS growth. If I just sort of compare the 2, I would say, bottom line EPS growth maybe I would have expected something a little bit higher just given the margin opportunity."
— Amit Mehrotra, UBS

A: "For starters, our midpoint of the guide for 2026 is up by 23¢. So we are starting at a higher baseline. On the top line, we remain very confident on performing at upper end of our 4% to 6% guide.… I cannot tell you specifics because I will be giving you a guide, which I think we will have to wait for February when we plan to come back there. But final comment I will make is, directionally, we are on a road to deliver our $12 or better"
— Vimal Kapur, Chairman & CEO

Assessment: Management declined to repeat 15% and anchored instead to "$12 or better" for 2029, which from the new $8.425 midpoint is about 12.5% a year. That is the right anchor for our model. The useful new detail is "upper end" of 4–6% organic growth for 2027, a stronger statement than the prepared remarks.

What Explains the Implied Fourth-Quarter Slowdown

With backlog and short-cycle orders both strong, a questioner asked why the fourth-quarter guide implies slower organic growth than the third quarter. Management attributed it to conservatism and project timing rather than any change in demand.

Q: "Could we just start with the 4Q outlook I think you are embedding a little bit of a deceleration in organic growth. The backlog is obviously so strong, short cycle order growth is still strong. Can you maybe talk through the expectations by segment, like what is driving the modest deceleration that you have embedded for 4Q?"
— Nicole DeBlase, Deutsche Bank

A: "I would say probably this is just more of conservatism than anything else.… On product side, both BA and IA booked in third quarter. High single digit, double digit growth. So we feel good about that. And then projects are incrementally better."
— Michal Stepniak, SVP & CFO

Assessment: Two raises since the June standalone guide give this claim some credibility. The product-order detail, high-single to double-digit bookings in Building and Industrial Automation, is also the best rebuttal to the orders concern, because short-cycle product orders convert within the guided period.

Whether High Refinery Utilization Is Pushing Aftermarket Work Into 2027

A questioner asked whether strong refining margins were leading refiners to run hard and defer work that requires a shutdown. Management confirmed that some demand is moving to later periods, separated the services that can be done online from those that cannot, and gave a 2027 catalyst outlook.

Q: "On the refining side of the business, are you seeing any deferrals just given where crack spreads are, refiners may be running out hotter a little bit, given profitability looks really, really good right now. So are you seeing like any of that like business maybe pushing out into next year?"
— Joe Ritchie, Goldman Sachs

A: "So to me, there is some demand moving right, but it is not a lost demand. it is moving. it is kind of pent up demand, which will eventually show up.… Next year, we see overall catalyst to be very stable. Mid single digit growth."
— Vimal Kapur, Chairman & CEO

Assessment: The admission is useful, and the 2027 catalyst figure is the most important number in the answer. Mid-single-digit catalyst growth next year is a slowdown from the second half of 2026, and catalysts are the high-margin part of the segment. That sits awkwardly with the CFO's statement that catalyst mix will help Process Automation margins expand in the second half of 2027, and it is why we model that recovery cautiously.

How Forge Is Sold, and a Lower Growth Rate for Recurring Revenue

A questioner asked how the Forge software platform reaches customers and whether it is priced separately. Management described three sales motions and, in doing so, lowered the 2026 growth expectation for recurring revenue.

Q: "But how do you go to market with FORGE then? Is this Is this kind of is it getting wrapped in as a standard offering with every install or is it come in as kind of a sidecar if you will and price separately?"
— Scott Davis, Melius Research

A: "So all 3 sales motions are in place, and as we talked about in Investor Day, we expect our ARR to grow Our aspiration is 15%. We wanna have high aspiration. This year, probably, we will be slightly shy of that, more likely 12-13%."
— Vimal Kapur, Chairman & CEO

Assessment: In July, management said it expected about 15% recurring-revenue growth in 2026, taking it from about $900M to a little over $1B. It now expects 12–13% and "just shy" of $1B. The amount is small, but it is one of two stated 2026 targets that softened this quarter, alongside the fourth-quarter margin exit, and it slows the services-and-software mix shift that supports the long-term margin goal.

What They're NOT Saying

1. Nothing on Quantinuum. The stake did not come up in prepared remarks or Q&A, even though its market value has fallen about $2.5B below its carrying value and it produced a $147M equity loss in the quarter. Management did not address whether an impairment review is under way, and gave no update on the plan promised by early 2027.
2. The unadjusted order growth figure. Management presented total orders only on a normalized basis that excludes a large prior-year award. Because that adjustment removes the award from last year's base, the unadjusted figure was lower than 3%. Investors were not given it on the call.
3. Why stock compensation nearly quintupled. Stock compensation expense was $104M against $22M a year ago and $78M for the first half of 2026 combined. It sits inside adjusted EPS, so the beat absorbed it, but whether it reflects one-time spin-related award conversions or a new run rate matters for 2027 and was not explained.
4. How much separation cash is still to come. Free cash flow excludes separation-related payments, $158M this quarter and about $0.5B for the year. Management did not say how much continues into 2027 or how 2027 conversion compares on an unadjusted basis.
5. Why delivery performance is at 60% rather than near 80%. The July commentary described on-time delivery "trending from 40% towards 80%." This quarter it is about 60%, with the starting point restated to "just shy of 40%." The gap was not reconciled.
6. A Middle East update. In July, management expected Middle East revenue up high single digits for 2026 and orders up about 40%, under a guide that assumed no improvement in conditions. The region was mentioned only among sources of order strength this quarter, with no update to those figures.
7. How catalyst mix lifts 2027 margins if catalyst growth normalizes. The CFO expects Process Automation margins to expand in the second half of 2027 as catalyst mix improves, while the CEO expects catalyst growth to normalize to mid-single digits next year. Both may hold if projects slow faster than catalysts, but no one connected them.

Market Reaction

• Pre-print setup: HON closed at $214.73 on October 21. That was 13.1% below the $247.05 close on July 28, when we upgraded, while the S&P 500 rose 4.4% over the same span. The stock peaked at $248.79 on August 4, fell to $201.38 on September 14, and recovered only partly into the print. Most of the decline came in August, the month the spun-off Aerospace company cut its 2026 outlook; we cannot tie it to a Honeywell Technologies disclosure.
• Reaction session (October 22, before-open reporter): The stock opened at $213.50, down 0.6%, and fell to $205.20, down 4.4%, within the first twenty minutes of regular trading. It then recovered, through one mid-morning pullback, crossed the prior close before noon, and closed at $218.31, up 1.7% or $3.58, near the day's high. Volume was 5.3M shares against a 2.7M thirty-day average (2.0x).
• Market and peer context: The S&P 500 fell 1.2% on the session, and automation and electrical peers fell between about 2% and 6%, so HON outperformed the index by about 3 points and most peers by more.
• Follow-through: HON rose another 1.3% to $221.15 on October 23 as the S&P 500 fell 0.5%.

The session had two halves. The early weakness is consistent with what a screen would flag first: revenue slightly below consensus, fourth-quarter revenue guided about 3% lower year over year as the divested businesses drop out, and an order figure that needed adjustment to show growth. The low came within twenty minutes of the open, and the stock then recovered for the rest of the day, through one mid-morning pullback, closing near its high on double the average volume. We cannot tie the reversal to any single exchange. At least part of the Street said afterward that the call had addressed the early concern about orders, and a recovery that builds through a whole session looks more like a considered reassessment than a reflex.

The relative move matters more than the absolute one. On a day when the index fell 1.2% and peers fell more, a 1.7% gain was a real vote of confidence, and the 1.3% follow-through on a down tape suggests it was not short covering. It also frames the setup. The stock entered the print at roughly 21x our 2027 estimate net of the Quantinuum stake at market, against about 24x on the same estimate and method at our July upgrade. Two days of relative strength recovered only a small part of that de-rating.

Street Perspective

Debate: Is the Orders Slowdown a Comparison Effect or a Turn?

Bull view: The constructive camp argues that a single prior-year award of several hundred million dollars distorts a quarter's order rate, that backlog still grew 7% to nearly $19B, and that short-cycle orders up 8% plus a high-single-digit fourth-quarter guide show demand intact. At least part of the Street left the call saying the early concern about orders had been addressed.

Bear view: Skeptics note that short-cycle growth slowed from double digits, book-to-bill fell to about 1.0, and management chose to present a normalized number. They argue industrial short-cycle demand tends to roll over first in exactly this way, and a strong fourth-quarter order guide one month in is a forecast, not a fact.

Our take: The bulls have the better of the long-cycle argument and the bears have a point on short-cycle. We moved the pillar to at-risk rather than broken. A fourth-quarter print that meets the high-single-digit guide moves it back; a miss would make two soft quarters, which is a trend.

Debate: Is the De-Rating an Entry Point or a Verdict?

Bull view: The constructive camp points out that 2026 EPS guidance has risen twice since June while the stock fell, that stranded costs finish ahead of plan, and that the company trades near 23x next year's earnings for low-teens EPS growth and 22% margins. Price-target changes after the print were small upward adjustments, consistent with estimates rising on a lower price.

Bear view: Skeptics argue the July multiple simply reflected spin enthusiasm and that the stock is finding a level appropriate for an industrial whose margin expansion is front-loaded and largely mechanical. With the corporate tailwind fading in 2027, they see operating margin expansion slowing just as the multiple has to be justified by operations.

Our take: We think the bears are right that 28x was too high a starting point, which is why we cut our multiple. But the de-rating has gone further than the fundamentals justify: on our current 2027 estimate the operating business went from about 24x at our upgrade to about 21x before the print, net of the stake at market, while the 2026 guide rose. That is the setup we want to own.

Debate: Does PA&T's Margin Dilution Matter If the Growth Is Real?

Bull view: One camp argues that project-led growth is the leading edge of a multiyear cycle, that each project expands the installed base that later buys high-margin catalysts, software and services, and that margin dilution from an acquisition is temporary by construction.

Bear view: The other camp notes that the segment's margin will sit near 21.5% for at least three more quarters, that refinery turnarounds are being deferred, and that catalyst growth normalizes next year, so the margin recovery depends on a mix shift that management's own commentary does not fully support.

Our take: The growth is worth more than the dilution costs, and the dilution is visible and guided. We side with the bulls on value and the bears on timing, and model segment margin recovery as a late-2027 and 2028 event.

Debate: Quantinuum: Option or Overhang?

Bull view: One camp treats the stake as a free option: it contributes nothing to adjusted earnings, management has promised a plan, and any monetization would fund debt reduction or acquisitions without diluting the $12 target.

Bear view: The other camp notes that the market value of the stake has fallen well below book value, that an impairment is possible, that a sale of a large block in a volatile, newly public stock would be difficult, and that the equity losses keep coming.

Our take: Both are partly right. We now value the stake at $12–14 per share, a modest discount to market, and treat any plan in early 2027 as a catalyst only if it includes monetization. An impairment would be non-cash and excluded from adjusted EPS, but it would be poorly received.

Model Update & Valuation Framework

Estimates. Our 2026 estimate moves to the $8.425 guide midpoint: an implied $5.98 for the first nine months plus $2.42–2.47 for the fourth quarter. For 2027 we start from about $20.05B of 2026 sales, remove roughly $1.4B for the seven months the divested businesses were owned, add a full year of the acquired catalyst business, and apply 5.5% organic growth for about $20.0B of revenue. We assume a 22.0–22.5% segment margin, starting from the ~22% fourth-quarter exit less the usual fourth-quarter seasonal lift (Q4 2025 ran about 50bp above the full year), adding about 60bp of operational expansion and a smaller corporate tailwind, and holding Process Automation near 21.5% through mid-year. Below the line, debt repayment and lower cash balances largely offset, leaving net interest modestly lower. That produces about $9.45 of adjusted EPS, up 12%, within a $9.30–9.60 range. Each 50bp of segment margin moves the estimate by about $0.25.

Valuation. At $221.15 and 319.2M diluted shares, HON's market capitalization is about $70.6B. That is 26.2x the 2026 guide midpoint and 23.4x our 2027 estimate. Net of the Quantinuum stake at market, about $14.20 per share, the operating business trades at 24.6x 2026 and 21.9x 2027. We set fair value at $239–260: 24–26x our $9.45 for the operating business plus $12–14 for the stake. The midpoint of $249 implies about 13% upside, plus a 1.3% yield on the $0.70 quarterly dividend, for a 12-month total return near 14%.

Why we cut the multiple. In July we applied 28x, a premium to the roughly 24.5x the market was then paying for the operating business on our 2027 estimate, on the argument that first-year credibility would earn a premium. Management delivered the credibility but the market did not pay the premium, and we do not think it is right to hold a multiple the market has moved away from without new evidence. Our 24–26x brackets the July market multiple rather than our own July premium. The cross-check is cash: at $249, our 2027 free cash flow estimate of about $2.7B, at the 90% conversion management targets, is a 3.4% yield, which with long-run growth of 5–6% implies a return near 8.5–9.5%, a reasonable cost of equity for this business. The change from $280 breaks down as about −$28 for the lower multiple, −$7 for the stake and +$4 for the higher estimate.

Downside and upside cases. In our bear case, the order slowdown reaches 2027 revenue, Process Automation margins stay diluted all year and Industrial Automation stays at low-single-digit growth; 2027 EPS lands near $8.95, the market pays 20x (close to the roughly 19.5x it paid for the operating business at the September low) and the stake is worth $9, for $188, or 15% below today. In our bull case, the fourth-quarter order guide is met, 2027 organic growth is at the top of the algorithm and EPS reaches $9.80, the market pays 27x and Quantinuum recovers partway to $18 per share, for $283, or 28% above today. The base case sits closer to the bull than to the bear, and the guide history (two raises since the June standalone guide, the latest putting the low end above the old high end) leads us to weight it heavily. That asymmetry, with estimates rising while the price fell, supports Outperform. The order deceleration and the Quantinuum mark reduce conviction to 6/10.

Thesis Scorecard Post-Earnings

Grading the standing thesis carried from the July recap. Bull 1 (the sum-of-the-parts unlock) and Bull 2 (Aerospace) were retired in July and are not repeated. No pillars are added this quarter.

Overall: Thesis unchanged in direction, with the operating case stronger and the valuation supports weaker. The two bear points that worried us most in July, Process Automation conversion and full valuation, have both eased: the first because the revenue arrived, the second because the price fell. Two bull pillars move to at-risk, orders on a single soft quarter and Quantinuum on a falling share price. The standalone algorithm, which is the heart of the case, was strengthened.

Action: Maintain Outperform, fair value $239–260. Add on further weakness ahead of the fourth-quarter orders print, which is the next decisive data point. Move to Hold if fourth-quarter orders miss the normalized high-single-digit guide without a timing explanation, or if the February guide implies 2027 EPS growth below 10%. Move to Underperform only if orders decline on a normalized basis for a second quarter and the 2029 framework is walked back.

Bottom Line: The Business Did What We Asked, the Price Did Not

Three months ago we upgraded Honeywell Technologies to Outperform at $247.05 and named one thing that had to go right: Process Automation had to turn a book-to-bill above 1.2 into revenue in the second half. It did, at +8% organic in the first quarter of that half. Company organic growth reached 7%, above the three-year target. Stranded costs will be gone by year-end, ahead of the timing set in July. The full-year EPS guide rose for the second time since the June standalone guide, and its new low end is above the old high end. The stock fell 13% into the print while the market rose 4%, so on the scorecard that matters to a reader, our July call is behind.

Part of that is our own error. We paid a 28x multiple in our base case for a credibility premium the market did not grant, and we valued the Quantinuum stake at a level its share price has not supported. We correct both here, and the fair value falls to $239–260. Part of it is the market. On our current 2027 estimate, and net of the stake at market, the operating business went from about 24x to about 21x while management raised the guide, which is a de-rating the fundamentals did not earn.

The quarter was not flawless. Three-quarters of the margin gain came from a corporate line that has almost finished shrinking, including a new trademark income stream that we take to be the Aerospace agreement. Orders slowed and had to be normalized to show growth. The fourth-quarter margin exit was trimmed, recurring-revenue growth was lowered, and Industrial Automation's delivery metric is behind the pace implied in July. These are the reasons conviction drops a notch.

But the trade-off now favors the buyer more than it did in July. At $221.15 the stock trades at 23.4x a 2027 estimate that has gone up, for a company that has raised its guide twice since June and has a specific, gradeable fourth-quarter order guide to report in February. The base case offers about 13% plus the dividend, the bear case about 15% downside, and the bull case about 28% upside. Maintaining Outperform, fair value $239–260.